|
|
Hookipa Pharma inc (NASDAQ: HOOK) |
|
Overall company Market Share Q4 2024 |
*Market share is calculated based on total revenue.
News about Hookipa Pharma inc Contracts |
July 1, 2024
Combining the articles:HOOKIPA Pharma Inc. made an elec...
|
May 23, 2024
CSIMarket.com - May 23, 2024HOOKIPA Pharma Inc. (NASDAQ: HOOK, HOOKIPA), a biopharmaceutical company focused on developing immunotherapeutics based on its innovative arenavirus platform, recently released updated positive results from its Phase 1/2 clinical trial of HB-200. The trial investigated the potential of HB-200 in treating human papillomavirus 16 positive (HPV16+) head and neck cancers. The announced data, published in the company s abstract for the American Society for Clinical Oncology (ASCO) 2024 Annual Meeting, provides crucial support for the design of the upcoming pivotal Phase 2/3 trial for HB-200 in combination with pembrolizumab as a first-line treatment.The published data from the Phase ...
|
Publicly Traded Peers of Hookipa Pharma inc
Iovance Biotherapeutics Inc
Share Performance
-54.56%
This Year
|
Iovance Biotherapeutics Inc
Profile
Iovance Biotherapeutics Inc operates on a business model centered around developing and commercializing novel cancer immunotherapy treatments. The company focuses on utilizing its proprietary Tumor Infiltrating Lymphocyte (TIL) therapy, which involves collecting and expanding a patient's own immune cells to target and kill cancer cells. Iovance primarily seeks to advance its TIL therapy candidates through clinical trials and collaborations while aiming to provide effective and personalized treatment options for cancer patients.
More about Iovance Biotherapeutics Inc 's Market Share
|
Bluebird Bio Inc
Share Performance
-1.52%
Over The Past 5 Days
|
Bluebird Bio Inc
Profile
Bluebird Bio Inc's business model focuses on developing gene therapies for severe genetic diseases and cancer. They collaborate with academic and industry partners to leverage their gene editing and cell-based technologies for discovering potential treatments and advancing these therapies through clinical trials.
More about Bluebird Bio Inc 's Market Share
|
Gilead Sciences Inc
Share Performance
+47.47%
One Year
|
Gilead Sciences Inc
Profile
Gilead Sciences Incs business model centers on researching, developing, and marketing innovative medicines, primarily targeting antiviral therapies. They focus on addressing unmet medical needs to enhance patient health globally.
More about Gilead Sciences Inc 's Market Share
|
Novavax inc
Share Performance
-11.32%
This Year
|
Novavax inc
Profile
Novavax Inc is a biotechnology company focused on the discovery, development, and commercialization of novel vaccines. They aim to leverage their proprietary recombinant nanoparticle vaccine technology platform to address a wide range of infectious diseases. By collaborating with partners and conducting clinical trials, Novavax works towards bringing innovative vaccines to the global market.
More about Novavax inc's Market Share
|
Sio Gene Therapies Inc
Share Performance
+22.88%
30 Days
|
Sio Gene Therapies Inc
Profile
Sio Gene Therapies Inc operates with a business model focused on developing and commercializing gene therapies to treat and potentially cure various neurological genetic diseases. Their approach involves leveraging cutting-edge gene therapy technology to address unmet medical needs and improve patients' quality of life.
More about Sio Gene Therapies Inc 's Market Share
|
Bellicum Pharmaceuticals Inc
Share Performance
-91.20%
One Year
|
Bellicum Pharmaceuticals Inc
Profile
Bellicum Pharmaceuticals Inc's business model is focused on the development and commercialization of innovative cellular immunotherapies for the treatment of cancers and other serious diseases.
More about Bellicum Pharmaceuticals Inc 's Market Share
|
Athersys Inc
Share Performance
0.00%
Over The Past 5 Days
|
Athersys Inc
Profile
Athersys Inc's business model revolves around the development and commercialization of novel cellular therapeutics.
More about Athersys Inc's Market Share
|
Hst Global Inc
Share Performance
0.00%
One Year
|
Hst Global Inc
Profile
HST Global Inc is a diversified company that operates through its subsidiaries in various sectors, including telecommunications, health and wellness, and alternative energy. Their business model focuses on acquiring and developing innovative technologies and solutions to provide sustainable and efficient services in these industries.
More about Hst Global Inc 's Market Share
|
Geron Corp
Share Performance
+4.60%
Over The Past 5 Days
|
Geron Corp
Profile
Geron Corp is a biopharmaceutical company that focuses on the discovery and development of therapeutic products for the treatment of cancer and chronic degenerative diseases. Their business model is based on researching and identifying innovative drug candidates, conducting preclinical and clinical trials to evaluate their safety and efficacy, and ultimately partnering with larger pharmaceutical companies for late-stage clinical development and commercialization. Geron Corp aims to leverage their scientific expertise and strategic collaborations to bring novel therapies to market and improve patient outcomes.
More about Geron Corp's Market Share
|
Theriva Biologics inc
Share Performance
-6.15%
This Quarter
|
Theriva Biologics inc
Profile
Theriva Biologics Inc operates as a biotechnology company that focuses on the discovery, development, and commercialization of innovative and targeted therapies for various diseases. Their business model is centered around research and development, aiming to create new biologic drugs and bring them to the market to address unmet medical needs.
More about Theriva Biologics inc 's Market Share
|
Longeveron Inc
Share Performance
-51.57%
One Year
|
Longeveron Inc
Profile
Longeveron Inc's business model involves the development and commercialization of regenerative medicine products using mesenchymal stem cells for various medical conditions.
More about Longeveron Inc 's Market Share
|
Adicet Bio Inc
Share Performance
-23.39%
30 Days
|
Adicet Bio Inc
Profile
Adicet Bio Inc's business model involves the development and commercialization of cell therapy medications for various diseases.
More about Adicet Bio Inc's Market Share
|
Nkarta Inc
Share Performance
-7.41%
Over The Past 5 Days
|
Nkarta Inc
Profile
Nkarta Inc is a biotechnology company with a business model centered on developing and commercializing engineered natural killer (NK) cell therapies for cancer patients. By utilizing proprietary technologies and expertise in genetic engineering, the company aims to enhance the therapeutic potential of NK cells and address unmet needs in the field of oncology. Nkarta Inc focuses on research, development, and production of these advanced cell therapies, collaborating with partners and regulators to bring innovative treatments to patients.
More about Nkarta Inc 's Market Share
|
Genprex Inc
Share Performance
-61.55%
This Quarter
|
Genprex Inc
Profile
Genprex Inc's business model focuses on the development and commercialization of gene therapies for the treatment of cancer.
More about Genprex Inc 's Market Share
|
2seventy Bio Inc
Share Performance
+65.55%
This Quarter
|
2seventy Bio Inc
Profile
2seventy Bio Inc operates on a business model centered around the development and commercialization of innovative genetic therapies. They strive to harness the power of biotechnology to address complex diseases and improve patient outcomes. By advancing their proprietary gene delivery technologies and collaborating with industry partners, they aim to create scalable treatments that revolutionize the field of genetic medicine.
More about 2seventy Bio Inc 's Market Share
|
Immix Biopharma Inc
Share Performance
+4.05%
Over The Past 5 Days
|
Immix Biopharma Inc
Profile
ImmIx Biopharma Inc is a biotechnology company that focuses on developing novel therapeutics for the treatment of cancer. Their business model involves conducting extensive research and development to discover and optimize drug candidates, followed by preclinical and clinical testing to assess their safety and effectiveness. They aim to collaborate with pharmaceutical companies or seek licensing agreements to further develop and commercialize their biopharmaceutical products.
More about Immix Biopharma Inc 's Market Share
|
Merus N v
Share Performance
+11.28%
This Quarter
|
Merus N v
Profile
Merus N V is a biotechnology company that operates using a differentiated and competitive business model. Their approach involves strategically targeting and developing bispecific antibodies to treat various types of cancer, leveraging their proprietary technologies and expertise in the field. By focusing on innovative research, efficient drug discovery, and partnerships, they aim to improve patient outcomes and drive growth in the oncology market.
More about Merus N v 's Market Share
|
Durect Corp
Share Performance
+4.81%
30 Days
|
Durect Corp
Profile
Durect Corp operates as a specialty pharmaceutical company that develops and commercializes innovative products for the treatment of chronic diseases. Their business model revolves around the research, development, and commercialization of their proprietary drug delivery technologies and therapeutics to address unmet medical needs.
More about Durect Corp's Market Share
|
Hutchmed china Limited
Share Performance
-8.54%
One Year
|
Hutchmed china Limited
Profile
Hutchmed China Limited operates on a vertically integrated platform, focusing on the discovery, development, and commercialization of targeted therapeutics for oncology and immunological diseases. The company employs a comprehensive business model that encompasses research and development, manufacturing, marketing, and sales in order to deliver innovative drugs to patients. By leveraging its internal capabilities and strategic partnerships, Hutchmed China aims to transform the treatment landscape and improve the lives of patients in China and around the world.
More about Hutchmed china Limited's Market Share
|
Kezar Life Sciences Inc
Share Performance
-10.35%
This Year
|
Kezar Life Sciences Inc
Profile
Kezar Life Sciences Inc is a biotechnology company that focuses on developing novel small molecule therapeutics. Their business model revolves around the discovery and development of innovative drugs to target autoimmune and inflammatory disorders, aiming to address unmet medical needs. They primarily operate by conducting extensive research and conducting clinical trials to deliver effective treatments for patients.
More about Kezar Life Sciences Inc 's Market Share
|
Point Biopharma Global Inc
Share Performance
+0.40%
Over The Past 5 Days
|
Point Biopharma Global Inc
Profile
Point Biopharma Global Inc is a pharmaceutical company that specializes in the development and commercialization of innovative radiopharmaceuticals for cancer treatment. Their business model involves leveraging advanced imaging technologies and targeted therapies to provide precise and personalized treatments to patients. By focusing on radiopharmaceuticals, Point Biopharma aims to revolutionize cancer therapy and improve patient outcomes.
More about Point Biopharma Global Inc 's Market Share
|
Alaunos Therapeutics Inc
Share Performance
-7.45%
30 Days
|
Alaunos Therapeutics Inc
Profile
Alaunos Therapeutics Inc is a biotechnology company that operates on a research and development business model. Their focus is on discovering and developing innovative therapies for various diseases and medical conditions. Through their scientific expertise and collaborations, they aim to bring novel treatments to market to improve patient outcomes.
More about Alaunos Therapeutics Inc 's Market Share
|
Matinas Biopharma Holdings Inc
Share Performance
+2.02%
This Year
|
Matinas Biopharma Holdings Inc
Profile
Matinas Biopharma Holdings Inc operates as a clinical-stage biopharmaceutical company. Their business model centers around developing therapeutics through the utilization of lipid nano-crystal (LNC) platform technologies. These technologies enable the effective delivery of drugs to improve patient outcomes in various diseases and conditions such as fungal infections, viral infections, and cancer.
More about Matinas Biopharma Holdings Inc 's Market Share
|
Opko Health Inc
Share Performance
+24.14%
This Year
|
Opko Health Inc
Profile
Opko Health Inc is a biotechnology and pharmaceutical company that operates through various business segments. The company primarily focuses on diagnostics, developing and commercializing novel diagnostic tests for various conditions. Additionally, Opko Health engages in the production and sale of pharmaceuticals and vaccines, as well as the research and development of new medical technologies.
More about Opko Health Inc 's Market Share
|
Emergent Biosolutions Inc
Share Performance
-29.82%
This Quarter
|
Emergent Biosolutions Inc
Profile
Emergent Biosolutions Inc's business model focuses on developing and manufacturing specialty products for the prevention and treatment of public health threats.
More about Emergent Biosolutions Inc 's Market Share
|
Organon and Co
Share Performance
+2.87%
This Year
|
Organon and Co
Profile
Organon and Co's business model revolves around developing and manufacturing pharmaceutical products.
More about Organon and Co 's Market Share
|
Regeneron Pharmaceuticals Inc
Share Performance
-5.39%
30 Days
|
Regeneron Pharmaceuticals Inc
Profile
Regeneron Pharmaceuticals Inc operates a business model centered on the discovery and commercialization of cutting-edge biopharmaceuticals, particularly in the fields of ophthalmology, oncology, immunology, and rare diseases. They leverage their strong research and development capabilities, including their proprietary technologies, to create innovative therapies that address unmet medical needs. Additionally, Regeneron forms strategic collaborations and partnerships to enhance their development pipeline and expand market access for their products.
More about Regeneron Pharmaceuticals Inc 's Market Share
|
Astrazeneca Plc
Share Performance
+0.50%
30 Days
|
Astrazeneca Plc
Profile
AstraZeneca Plc is a global biopharmaceutical company focused on the research, development, and commercialization of innovative medicines. Their business model involves investing extensively in research and development to discover novel treatments for a wide range of diseases. AstraZeneca then markets and sells these medicines globally, collaborating with healthcare providers and leveraging their strong sales and distribution networks.
More about Astrazeneca Plc's Market Share
|
Sanofi
Share Performance
+5.12%
30 Days
|
Sanofi
Profile
Sanofi's business model revolves around the development, production, and distribution of pharmaceutical products. They aim to innovate and provide healthcare solutions across various therapeutic areas to improve patients' lives worldwide. Sanofi collaborates with partners and healthcare professionals to ensure effective delivery of their products and to address evolving patient needs.
More about Sanofi's Market Share
|
Novartis Ag
Share Performance
+15.43%
This Year
|
Novartis Ag
Profile
Novartis AG's business model is centered around the development, manufacturing, and marketing of innovative pharmaceutical products.
More about Novartis Ag's Market Share
|
Boundless Bio Inc
Share Performance
0.00%
One Year
|
Boundless Bio Inc
Profile
Audentes Therapeutics Inc is a biotechnology company focused on developing and commercializing innovative gene therapies for serious rare diseases. Their business model revolves around conducting extensive research and development to design and produce these gene therapies. They then collaborate with healthcare providers and regulatory bodies to gain necessary approvals and commercialize their therapies, aiming to provide effective treatments for patients suffering from rare diseases.
More about Boundless Bio Inc 's Market Share
|
Dmk Pharmaceuticals Corporation
Share Performance
-65.93%
30 Days
|
Dmk Pharmaceuticals Corporation
Profile
DMK Pharmaceuticals Corporation has a business model focused on the development, manufacturing, and distribution of pharmaceutical products.
More about Dmk Pharmaceuticals Corporation's Market Share
|
60 Degrees Pharmaceuticals Inc
Share Performance
+35.11%
This Year
|
60 Degrees Pharmaceuticals Inc
Profile
60 Degrees Pharmaceuticals Inc is a pharmaceutical company focused on the development and commercialization of innovative treatments for infectious diseases, particularly malaria.
More about 60 Degrees Pharmaceuticals Inc 's Market Share
|
Innovation1 Biotech Inc
Share Performance
0.00%
30 Days
|
Innovation1 Biotech Inc
Profile
The business model of Innovation1 Biotech Inc involves developing and commercializing innovative biotechnological products and solutions for various industries. The company focuses on research, development, and manufacturing, aiming to provide cutting-edge biotech solutions that meet the needs of diverse markets.
More about Innovation1 Biotech Inc 's Market Share
|
Humanigen Inc
Share Performance
-99.00%
This Year
|
Humanigen Inc
Profile
Humanigen Inc is a biopharmaceutical company that develops and commercializes immunotherapy treatments to address serious diseases and medical conditions.
More about Humanigen Inc's Market Share
|
Actavia Life Sciences Inc
Share Performance
0.00%
Over The Past 5 Days
|
Actavia Life Sciences Inc
Profile
Rasna Therapeutics Inc is a biotechnology company that focuses on developing innovative therapies for the treatment of cancer and other diseases. Their business model revolves around leveraging cutting-edge research and technology to discover and develop novel drug candidates. They aim to partner with pharmaceutical companies or license their intellectual property to bring their therapies to market and ultimately improve patient outcomes.
More about Actavia Life Sciences Inc 's Market Share
|
International Stem Cell Corporation
Share Performance
+120.73%
One Year
|
International Stem Cell Corporation
Profile
International Stem Cell Corporation is a biotechnology company that focuses on developing and commercializing stem cell-based therapeutic products. They utilize their unique technology to derive unlimited amounts of pluripotent stem cells, enabling them to create therapeutics for various medical conditions.
More about International Stem Cell Corporation's Market Share
|
180 Life Sciences Corp
Share Performance
-59.21%
One Year
|
180 Life Sciences Corp
Profile
180 Life Sciences Corp is a biotechnology company engaged in the research and development of novel drugs that target inflammation and fibrosis to address various diseases such as fibrosis, inflammation, and pain.
More about 180 Life Sciences Corp's Market Share
|
Sunshine Biopharma Inc
Share Performance
-7.69%
30 Days
|
Sunshine Biopharma Inc
Profile
Sunshine Biopharma Inc is a pharmaceutical company that focuses on developing and commercializing drugs for the treatment of cancer and other diseases. They utilize their expertise in drug discovery and development to create innovative treatments that target specific molecular targets in order to deliver more effective and personalized therapies for patients.
More about Sunshine Biopharma Inc 's Market Share
|
Histogen Inc
Share Performance
0.00%
This Year
|
Histogen Inc
Profile
Histogen Inc operates as a biopharmaceutical company that focuses on developing and commercializing regenerative medicine therapies. Their business model revolves around researching and developing innovative products that stimulate the body's natural regenerative processes to treat various medical conditions and diseases. They aim to bring these therapies to market through partnerships, licensing agreements, and direct sales, providing healthcare solutions through their regenerative medicine technologies.
More about Histogen Inc 's Market Share
|
Tiziana Life Sciences Ltd
Share Performance
+23.33%
30 Days
|
Tiziana Life Sciences Ltd
Profile
Tiziana Life Sciences Ltd's business model focuses on the development and commercialization of innovative therapeutics in the field of immunology and oncology.
More about Tiziana Life Sciences Ltd's Market Share
|
Viracta Therapeutics Inc
Share Performance
-89.26%
This Quarter
|
Viracta Therapeutics Inc
Profile
Viracta Therapeutics Inc is a biopharmaceutical company focused on developing targeted therapies for viral-associated cancers. The company aims to advance research, develop innovative treatments, and commercialize products to improve the lives of patients suffering from these types of cancers.
More about Viracta Therapeutics Inc 's Market Share
|
Ayala Pharmaceuticals Inc
Share Performance
+11.11%
This Year
|
Ayala Pharmaceuticals Inc
Profile
Ayala Pharmaceuticals Inc is a biopharmaceutical company focused on developing targeted therapies for patients with rare and aggressive cancers. Their business model revolves around leveraging scientific expertise and strategic partnerships to advance their pipeline of potential treatments and ultimately bring them to market.
More about Ayala Pharmaceuticals Inc 's Market Share
|
Forte Biosciences Inc
Share Performance
-53.34%
One Year
|
Forte Biosciences Inc
Profile
Forte Biosciences Inc is a biotechnology company focused on developing and commercializing innovative solutions for the treatment of dermatological diseases. Their business model centers around researching, developing, and bringing to market products that address unmet needs in the field of skin health through their proprietary technology platform.
More about Forte Biosciences Inc 's Market Share
|
Hcw Biologics Inc
Share Performance
-10.41%
Over The Past 5 Days
|
Hcw Biologics Inc
Profile
HCW Biologics Inc is a biotechnology company that operates on a business model focused on the research, development, and commercialization of biologic therapies. The company primarily focuses on developing and manufacturing novel biological products for various medical conditions. Their business model involves collaboration with industry partners, conducting clinical trials, and securing regulatory approvals for the commercialization of their biologic therapies.
More about Hcw Biologics Inc 's Market Share
|
Renovorx Inc
Share Performance
-32.39%
One Year
|
Renovorx Inc
Profile
Renovorx Inc is a medical technology company specializing in the development of innovative treatments for cardiovascular diseases. Their business model focuses on creating and commercializing minimally invasive therapies for patients suffering from conditions like myocardial infarction and heart failure. By leveraging cutting-edge medical devices and procedures, Renovorx aims to provide effective and efficient treatments that can significantly improve patient outcomes and quality of life.
More about Renovorx Inc 's Market Share
|
Spero Therapeutics Inc
Share Performance
-10.63%
This Quarter
|
Spero Therapeutics Inc
Profile
Spero Therapeutics Inc's business model focuses on developing novel antibiotics to combat drug-resistant bacterial infections.
More about Spero Therapeutics Inc 's Market Share
|
Indaptus Therapeutics Inc
Share Performance
-11.33%
Over The Past 5 Days
|
Indaptus Therapeutics Inc
Profile
Indaptus Therapeutics Inc's business model focuses on developing and commercializing innovative therapies in the healthcare industry.
More about Indaptus Therapeutics Inc 's Market Share
|
Iterum Therapeutics Plc
Share Performance
-19.10%
This Quarter
|
Iterum Therapeutics Plc
Profile
Iterum Therapeutics Plc is a pharmaceutical company that focuses on the research, development, and commercialization of innovative anti-infectives for the treatment of serious and life-threatening infections. They aim to address unmet medical needs in this space by advancing their product candidates through clinical trials and ultimately bringing them to market.
More about Iterum Therapeutics Plc's Market Share
|
Ampio Pharmaceuticals inc
Share Performance
0.00%
This Quarter
|
Ampio Pharmaceuticals inc
Profile
Ampio Pharmaceuticals Inc is a biopharmaceutical company primarily focused on the development of therapies for debilitating diseases. Their business model revolves around identifying unmet medical needs and developing innovative drug candidates to address these needs. They aim to create value through successful clinical development and commercialization of their products, ultimately benefiting patients and generating revenue for the company.
More about Ampio Pharmaceuticals inc 's Market Share
|
Esperion Therapeutics inc
Share Performance
-24.55%
This Quarter
|
Esperion Therapeutics inc
Profile
Esperion Therapeutics Inc's business model focuses on the development and commercialization of innovative therapies for addressing cardiovascular diseases.
More about Esperion Therapeutics inc 's Market Share
|
Palatin Technologies Inc
Share Performance
-20.65%
30 Days
|
Palatin Technologies Inc
Profile
Palatin Technologies Inc has a business model focused on developing and commercializing innovative medicines in the field of reproductive healthcare and sexual dysfunction. The company's revenue streams primarily come from partnerships, licensing agreements, and product sales.
More about Palatin Technologies Inc 's Market Share
|
Leap Therapeutics Inc
Share Performance
-5.60%
Over The Past 5 Days
|
Leap Therapeutics Inc
Profile
Leap Therapeutics Inc. is a biopharmaceutical company with a business model focused on discovering and developing targeted therapies for cancer. They aim to leverage their expertise in identifying novel targets and developing antibody-based therapies to address unmet medical needs in oncology. By advancing their pipeline of innovative drugs, they seek to provide effective treatment options for patients and create value for stakeholders in the pharmaceutical industry.
More about Leap Therapeutics Inc 's Market Share
|
Cellectar Biosciences inc
Share Performance
-90.89%
One Year
|
Cellectar Biosciences inc
Profile
Cellectar Biosciences Inc is a biopharmaceutical company that focuses on the development of targeted cancer therapies. They utilize their proprietary drug conjugation platform to create targeted small molecules that can selectively bind and deliver radioactive isotopes directly to cancer cells. Their business model revolves around developing and commercializing these innovative therapies for the treatment of various types of cancer, aiming to improve patient outcomes and potentially revolutionize cancer treatment.
More about Cellectar Biosciences inc 's Market Share
|
Xenetic Biosciences Inc
Share Performance
-12.69%
One Year
|
Xenetic Biosciences Inc
Profile
Xenetic Biosciences Inc is a biopharmaceutical company that focuses on developing personalized therapeutics with the potential to improve patient outcomes. The company employs a business model centered around leveraging its proprietary drug development platform to partner with pharmaceutical companies and advance novel drug candidates through preclinical and clinical stages.
More about Xenetic Biosciences Inc 's Market Share
|
Xbiotech Inc
Share Performance
-54.13%
One Year
|
Xbiotech Inc
Profile
Xbiotech Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic antibodies. They seek to address unmet medical needs by leveraging their proprietary True Human antibody technology.
More about Xbiotech Inc 's Market Share
|
Decibel Therapeutics Inc
Share Performance
+136.63%
This Year
|
Decibel Therapeutics Inc
Profile
Decibel Therapeutics Inc is a biotechnology company that focuses on developing treatments for hearing loss and related disorders.
More about Decibel Therapeutics Inc 's Market Share
|
Journey Medical Corp
Share Performance
+8.10%
Over The Past 5 Days
|
Journey Medical Corp
Profile
Journey Medical Corporation is a pharmaceutical and medical device company that specializes in developing and commercializing innovative products for dermatology and aesthetics. Their business model revolves around conducting research and development to create new products, acquiring the necessary regulatory approvals, and partnering with healthcare professionals to effectively distribute and market these products. By focusing on dermatology and aesthetics, Journey Medical Corporation aims to address unmet medical needs and provide cutting-edge solutions to improve patient outcomes in these fields.
More about Journey Medical Corp's Market Share
|
Tff Pharmaceuticals Inc
Share Performance
-77.57%
Over The Past 5 Days
|
Tff Pharmaceuticals Inc
Profile
TFF Pharmaceuticals Inc's business model revolves around developing and commercializing novel drug therapies using its Thin Film Freezing (TFF) technology, which enhances the solubility and stability of drugs for improved delivery and patient outcomes. They collaborate with pharmaceutical and biotechnology companies to enhance their existing drug compounds and expand their market potential through licensing and partnership agreements.
More about Tff Pharmaceuticals Inc's Market Share
|
Casi Pharmaceuticals inc
Share Performance
-27.65%
One Year
|
Casi Pharmaceuticals inc
Profile
Casi Pharmaceuticals Inc. operates under a business model that focuses on the development and commercialization of innovative pharmaceutical products. They likely employ a combination of in-house research and development, partnerships, and licensing agreements to bring their products to market. The company may also engage in strategic marketing and distribution partnerships to ensure the successful commercialization of their therapeutics.
More about Casi Pharmaceuticals inc 's Market Share
|
Mineralys Therapeutics Inc
Share Performance
+39.88%
This Quarter
|
Mineralys Therapeutics Inc
Profile
Mineralys Therapeutics Inc is a biotechnology company that follows the business model of developing and commercializing novel therapeutics for various diseases. They focus on discovering and advancing small molecule drugs based on innovative research approaches. Their business model is centered around conducting preclinical and clinical trials, obtaining regulatory approvals, and ultimately bringing their therapeutic products to market for improved patient outcomes.
More about Mineralys Therapeutics Inc 's Market Share
|
Third Harmonic Bio Inc
Share Performance
-68.30%
This Year
|
Third Harmonic Bio Inc
Profile
Third Harmonic Bio Inc's business model centers around developing and commercializing innovative therapeutic solutions through the utilization of bioinformatics and genomics.
More about Third Harmonic Bio Inc 's Market Share
|
Immunome Inc
Share Performance
-9.51%
Over The Past 5 Days
|
Immunome Inc
Profile
Immunome Inc is a biotechnology company that focuses on developing novel immunotherapies. Their business model revolves around leveraging their proprietary discovery engine to identify therapeutic antibodies for infectious diseases and cancer. By collaborating with partners and through their own clinical development efforts, they aim to bring these promising treatments to the market.
More about Immunome Inc's Market Share
|
Takeda Pharmaceutical Company Limited
Share Performance
+9.60%
30 Days
|
Takeda Pharmaceutical Company Limited
Profile
Takeda Pharmaceutical Company Limited operates under a business model that primarily focuses on research, development, and commercialization of innovative pharmaceutical products. They collaborate with various stakeholders across the healthcare industry, including academia, biotechnology companies, and patient advocacy groups, to drive scientific advancements and understand patient needs. By leveraging their expertise, global presence, and strategic partnerships, Takeda aims to make a positive impact on patients' lives while ensuring long-term growth and sustainability.
More about Takeda Pharmaceutical Company Limited's Market Share
|
Mirati Therapeutics Inc
Share Performance
-0.14%
30 Days
|
Mirati Therapeutics Inc
Profile
Mirati Therapeutics Inc is a biotechnology company that focuses on the research, discovery, and development of precision oncology treatments for patients with cancer. Their business model involves leveraging their proprietary drug discovery platform to identify and develop targeted therapies, and collaborating with partners for the commercialization of their products.
More about Mirati Therapeutics Inc 's Market Share
|
Prometheus Biosciences Inc
Share Performance
+66.60%
This Quarter
|
Prometheus Biosciences Inc
Profile
Prometheus Biosciences Inc is a biotechnology company that operates on a subscription-based business model. Their platform offers personalized diagnostic tools and services to healthcare providers, enabling them to deliver targeted treatments for patients with gastrointestinal diseases. By providing ongoing support and monitoring, Prometheus aims to improve patient outcomes and revolutionize the management of chronic conditions in the field of gastroenterology.
More about Prometheus Biosciences Inc 's Market Share
|
Eli Lilly And Company
Share Performance
+7.65%
This Year
|
Eli Lilly And Company
Profile
Eli Lilly and Company operates as a global pharmaceutical firm that focuses on developing innovative medicines in areas such as diabetes, oncology, and neurodegeneration. Their business model emphasizes research and development, strategic partnerships, and a strong commitment to improving patient outcomes through advanced therapeutics.
More about Eli Lilly And Company's Market Share
|
Johnson and Johnson
Share Performance
+2.47%
30 Days
|
Johnson and Johnson
Profile
Johnson & Johnson operates as a multinational healthcare company with a diversified business model that spans pharmaceuticals, medical devices, and consumer health products. By focusing on innovation and strategic acquisitions, the company aims to improve global health and well-being.
More about Johnson and Johnson's Market Share
|
Merck and Co Inc
Share Performance
-1.77%
Over The Past 5 Days
|
Merck and Co Inc
Profile
Merck & Co. Inc. operates primarily as a research-driven pharmaceutical company, focused on the development, manufacturing, and marketing of prescription drugs and vaccines globally. It aims to address unmet medical needs through innovative research, collaborations, and rigorous clinical trials, while promoting patient well-being and contributing to global healthcare with high-quality, affordable medications.
More about Merck and Co Inc 's Market Share
|
Bristol myers Squibb Company
Share Performance
+6.06%
This Quarter
|
Bristol myers Squibb Company
Profile
Bristol Myers Squibb Company operates a research and development-driven business model, focusing on the discovery and delivery of innovative medicines for various diseases. It emphasizes collaboration with academic institutions, government entities, and other pharmaceutical firms to enhance its therapeutic portfolio and improve patient outcomes.
More about Bristol myers Squibb Company's Market Share
|
Sources: Hookipa Pharma inc and all companies mentioned above in this report
|
